44th Annual J.P. Morgan Healthcare Conference
Logotype for Neogen Corporation

Neogen (NEOG) 44th Annual J.P. Morgan Healthcare Conference summary

Event summary combining transcript, slides, and related documents.

Logotype for Neogen Corporation

44th Annual J.P. Morgan Healthcare Conference summary

15 Jan, 2026

Market Overview and Industry Trends

  • Food safety and animal health markets are expanding due to increased food complexity, stricter regulations, and higher consumer expectations.

  • Regulatory mandates, not government funding, drive demand for food safety solutions, providing a stable market tailwind.

  • The addressable market is estimated at $11B, with strong growth potential across USAC, EMEA, LATAM, and APAC regions.

  • The company holds market leadership in pathogen detection and hygiene indicators, serving a broad customer base from small processors to global protein producers.

  • Innovation cycles are faster in food safety compared to human diagnostics due to lower regulatory hurdles.

Strategic Direction, Vision, and Turnaround Plan

  • The vision is to fuel global food security with a safe, sufficient, and sustainable food supply.

  • A new management team with turnaround experience has been assembled, restructuring the executive team for speed, accountability, and cross-functional execution.

  • The turnaround and growth strategy follows three phases: stabilize, accelerate, and expand, with a focus on top-line growth, cost management, and operational transformation.

  • Execution discipline, customer intimacy, and operational maturity are key to achieving market-leading performance.

  • Enhanced governance and controls are in place to improve cash predictability and risk management.

Portfolio Focus and Innovation

  • The portfolio is being refocused on higher-growth, more profitable markets, with divestiture of the genomics division expected by year-end.

  • PetrifilmⓇ, the flagship product, is central to the food safety offering, with a new production site in Lansing, Michigan, on track for completion by November 2026.

  • High-growth consumables include PetrifilmⓇ, pathogen testing, and biosecurity, with market CAGRs up to 12%.

  • Innovation is customer-need driven, with increased R&D and CapEx investment focused on scalable, high-return projects and a low-teens New Product Vitality Index.

  • End-to-end food safety solutions integrate products, analytics, and expert services, reinforcing brand authority and customer loyalty.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more